263 related articles for article (PubMed ID: 34074623)
1. Extracellular ATP and Adenosine in Cancer Pathogenesis and Treatment.
Chiarella AM; Ryu YK; Manji GA; Rustgi AK
Trends Cancer; 2021 Aug; 7(8):731-750. PubMed ID: 34074623
[TBL] [Abstract][Full Text] [Related]
2. Purinergic signalling in brain ischemia.
Pedata F; Dettori I; Coppi E; Melani A; Fusco I; Corradetti R; Pugliese AM
Neuropharmacology; 2016 May; 104():105-30. PubMed ID: 26581499
[TBL] [Abstract][Full Text] [Related]
3. Extracellular nucleotides as novel, underappreciated pro-metastatic factors that stimulate purinergic signaling in human lung cancer cells.
Schneider G; Glaser T; Lameu C; Abdelbaset-Ismail A; Sellers ZP; Moniuszko M; Ulrich H; Ratajczak MZ
Mol Cancer; 2015 Nov; 14():201. PubMed ID: 26597723
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and hypertension: Pivotal involvement of purinergic signaling.
Reichert KP; Castro MFV; Assmann CE; Bottari NB; Miron VV; Cardoso A; Stefanello N; Morsch VMM; Schetinger MRC
Biomed Pharmacother; 2021 May; 137():111273. PubMed ID: 33524787
[TBL] [Abstract][Full Text] [Related]
5. Regulation of innate immunity by the nucleotide pathway in children with idiopathic nephrotic syndrome.
Bertelli R; Bodria M; Nobile M; Alloisio S; Barbieri R; Montobbio G; Patrone P; Ghiggeri GM
Clin Exp Immunol; 2011 Oct; 166(1):55-63. PubMed ID: 21762125
[TBL] [Abstract][Full Text] [Related]
6. Complementary Role of P2 and Adenosine Receptors in ATP Induced-Anti-Apoptotic Effects Against Hypoxic Injury of HUVECs.
Feliu C; Peyret H; Poitevin G; Cazaubon Y; Oszust F; Nguyen P; Millart H; Djerada Z
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30909368
[TBL] [Abstract][Full Text] [Related]
7. ATP-induced vasodilation and purinergic receptors in the human leg: roles of nitric oxide, prostaglandins, and adenosine.
Mortensen SP; González-Alonso J; Bune LT; Saltin B; Pilegaard H; Hellsten Y
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1140-8. PubMed ID: 19118095
[TBL] [Abstract][Full Text] [Related]
8. Conversion of extracellular ATP into adenosine: a master switch in renal health and disease.
Dwyer KM; Kishore BK; Robson SC
Nat Rev Nephrol; 2020 Sep; 16(9):509-524. PubMed ID: 32641760
[TBL] [Abstract][Full Text] [Related]
9. Mitogenic signaling from P1 and P2 purinergic receptors to mitogen-activated protein kinase in human fetal astrocyte cultures.
Neary JT; McCarthy M; Kang Y; Zuniga S
Neurosci Lett; 1998 Feb; 242(3):159-62. PubMed ID: 9530930
[TBL] [Abstract][Full Text] [Related]
10. Extracellular nucleotide and nucleoside signaling in vascular and blood disease.
Idzko M; Ferrari D; Riegel AK; Eltzschig HK
Blood; 2014 Aug; 124(7):1029-37. PubMed ID: 25001468
[TBL] [Abstract][Full Text] [Related]
11. Reactive oxygen species contribute to the promotion of the ATP-mediated proliferation of mouse skeletal myoblasts.
Sciancalepore M; Luin E; Parato G; Ren E; Giniatullin R; Fabbretti E; Lorenzon P
Free Radic Biol Med; 2012 Oct; 53(7):1392-8. PubMed ID: 22917975
[TBL] [Abstract][Full Text] [Related]
12. Extracellular ATP signaling and clinical relevance.
Dou L; Chen YF; Cowan PJ; Chen XP
Clin Immunol; 2018 Mar; 188():67-73. PubMed ID: 29274390
[TBL] [Abstract][Full Text] [Related]
13. Extracellular adenosine 5'-triphosphate in pulmonary disorders.
Pelleg A
Biochem Pharmacol; 2021 May; 187():114319. PubMed ID: 33161021
[TBL] [Abstract][Full Text] [Related]
14. Purinergic signaling in kidney disease.
Menzies RI; Tam FW; Unwin RJ; Bailey MA
Kidney Int; 2017 Feb; 91(2):315-323. PubMed ID: 27780585
[TBL] [Abstract][Full Text] [Related]
15. Targeting P2 receptors in purinergic signaling: a new strategy of active ingredients in traditional Chinese herbals for diseases treatment.
Ai X; Dong X; Guo Y; Yang P; Hou Y; Bai J; Zhang S; Wang X
Purinergic Signal; 2021 Jun; 17(2):229-240. PubMed ID: 33751327
[TBL] [Abstract][Full Text] [Related]
16. Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft-versus-host disease.
Geraghty NJ; Watson D; Sluyter R
Immunol Cell Biol; 2019 Jul; 97(6):597-610. PubMed ID: 30957314
[TBL] [Abstract][Full Text] [Related]
17. The adenosinergic machinery in cancer: In-tandem insights from basic mechanisms to therapy.
Kang C; Liu L; Wu C; Li L; Jia X; Xie W; Chen S; Wu X; Zheng H; Liu J; Li R; Zeng B
Front Immunol; 2023; 14():1111369. PubMed ID: 36911717
[TBL] [Abstract][Full Text] [Related]
18. Extracellular nucleotides and nucleosides induce proliferation and increase nucleoside transport in human glioma cell lines.
Morrone FB; Jacques-Silva MC; Horn AP; Bernardi A; Schwartsmann G; Rodnight R; Lenz G
J Neurooncol; 2003 Sep; 64(3):211-8. PubMed ID: 14558596
[TBL] [Abstract][Full Text] [Related]
19. Targeting the CD73-adenosine axis in immuno-oncology.
Allard D; Chrobak P; Allard B; Messaoudi N; Stagg J
Immunol Lett; 2019 Jan; 205():31-39. PubMed ID: 29758241
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic potency of pharmacological adenosine receptors agonist/antagonist on cancer cell apoptosis in tumor microenvironment, current status, and perspectives.
Soleimani A; Bahreyni A; Roshan MK; Soltani A; Ryzhikov M; Shafiee M; Soukhtanloo M; Jaafari MR; Mashkani B; Hassanian SM
J Cell Physiol; 2019 Mar; 234(3):2329-2336. PubMed ID: 30191994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
